Liberty Posted August 21, 2014 Share Posted August 21, 2014 Very nice Q. Link to comment Share on other sites More sharing options...
snowball82 Posted August 21, 2014 Share Posted August 21, 2014 + 125 % profits / compound at 70 % cagr over last three years and just very nice ? :)? Can't wait to know more about the quarter results as they earn $0.06 and will have more products marketed soon. Link to comment Share on other sites More sharing options...
snowball82 Posted August 21, 2014 Share Posted August 21, 2014 Nice! I sold this way too early. Last traded $ 8.80 and if you watch this presentation about 2014 Q2, you could see futur growth. Let me know if you know what are next 4 international markets :) http://www.biosyent.com/q2-14/#.U_Z6WGK9KK1 Link to comment Share on other sites More sharing options...
jm25 Posted September 4, 2014 Author Share Posted September 4, 2014 I sold my position... I may get back in if the price becomes more reasonable. Link to comment Share on other sites More sharing options...
Liberty Posted September 4, 2014 Share Posted September 4, 2014 I sold my position... I may get back in if the price becomes more reasonable. Out of curiosity, what would be "more reasonable" for you? Are you looking for a specific multiple? Link to comment Share on other sites More sharing options...
snowball82 Posted September 5, 2014 Share Posted September 5, 2014 Now 10.67, more than 7 baggers for investors who bought last year but futur looks very promising. I expect .30-.40 (.40 max scenario) eps next year and my upside scenario is 1$ EPS 5 years from now. 4 new internationals markets should contribute next year. Link to comment Share on other sites More sharing options...
jouni1 Posted September 5, 2014 Share Posted September 5, 2014 congrats snowball! if your portfolio is doing half as good as the picks you post here you should be doing allright! 8) you seem to have growth investing figured out! Link to comment Share on other sites More sharing options...
snowball82 Posted September 5, 2014 Share Posted September 5, 2014 Thanks Jouni1, i appreciate the good word. My return over last decade was good, so I continue to work hard and more important ... have fun to learn every day. Link to comment Share on other sites More sharing options...
bsned2 Posted September 16, 2014 Share Posted September 16, 2014 Dumb American newbie questions ahead: OK Biosyent is a Canadian company and trades on the Toronto Exchange under the symbol RX. Quote today is 11.78. Still going strong. Can my guy at Deutsche Bank buy these shares for me? Also, it seems the stock is also traded as an OTC stock under the symbol BIOYF. I don't understand. Can anyone point me towards some reading to let me understand foreign exchanges (and my ability to access them) and OTC stocks? Thanks so much!! Link to comment Share on other sites More sharing options...
gary17 Posted September 16, 2014 Share Posted September 16, 2014 i believe they should be able to buy either the Rx of BIOYF shares - it's the same thing... but sometimes you may find the US shares are a bit cheaper as it is less liquid / efficient. Dumb American newbie questions ahead: OK Biosyent is a Canadian company and trades on the Toronto Exchange under the symbol RX. Quote today is 11.78. Still going strong. Can my guy at Deutsche Bank buy these shares for me? Also, it seems the stock is also traded as an OTC stock under the symbol BIOYF. I don't understand. Can anyone point me towards some reading to let me understand foreign exchanges (and my ability to access them) and OTC stocks? Thanks so much!! Link to comment Share on other sites More sharing options...
snowball82 Posted September 16, 2014 Share Posted September 16, 2014 Look Montavit products below. Maybe you could see some we know (Cathegel) or futurs prducts marketed in Canada. http://www.montavit.com/en/products/pharmaceuticals-rx Link to comment Share on other sites More sharing options...
snowball82 Posted October 20, 2014 Share Posted October 20, 2014 Again great Q. Q3 results out. Net income up 75 %. Eps .07 vs .04 http://www.biosyent.com/q3-14/2014-14.pdf Link to comment Share on other sites More sharing options...
Liberty Posted October 20, 2014 Share Posted October 20, 2014 Again great Q. Q3 results out. Net income up 75 %. Eps .07 vs .04 http://www.biosyent.com/q3-14/2014-14.pdf Very nice. Link to comment Share on other sites More sharing options...
snowball82 Posted October 26, 2014 Share Posted October 26, 2014 Take note of margin expansion this quarter : http://www.biosyent.com/q3-14/#.VExm6GK9KK0 Do you think $. 40 EPS next year is probable ? Snow Link to comment Share on other sites More sharing options...
Liberty Posted October 26, 2014 Share Posted October 26, 2014 Take note of margin expansion this quarter : http://www.biosyent.com/q3-14/#.VExm6GK9KK0 Do you think $. 40 EPS next year is probable ? Snow I find this and the international sales nice bonuses on top of the great model executed well. Not sure about next year's earnings, though, the range is quite wide with all the new products... But it's wide mostly on the upside so I'm not complaining. Link to comment Share on other sites More sharing options...
snowball82 Posted October 27, 2014 Share Posted October 27, 2014 We don't have to be a guru to forecast this company could be a $ 1 B market cap company one day if earning continue to compound like a snowball ! 15 % growth / quarter last 12 months. No no don't do the math $ 22 M market cap last year to ... Lol Link to comment Share on other sites More sharing options...
snowball82 Posted November 25, 2014 Share Posted November 25, 2014 Announce today about new launche and preparation for the next one (sixth product) in the first quarter of 2015. Probably the collaboration with Farma-Derma is going to bring more deals. The execution is almost perfect. http://finance.yahoo.com/news/biosyent-pharma-launches-proktis-m-130000890.html Based on last trade, valuation 39 X p/e last quarter annualized and 27 x p/e if next year EPS .40. Link to comment Share on other sites More sharing options...
snowball82 Posted January 22, 2015 Share Posted January 22, 2015 First coverage from an analyst today. If you like the story, try to get guidance from management in this report with the present funnel of opportunities amounts of annual sales (at peak penetration). If you add news products maybe you could also like potential EPS ! Link to comment Share on other sites More sharing options...
Liberty Posted January 22, 2015 Share Posted January 22, 2015 First coverage from an analyst today. If you like the story, try to get guidance from management in this report with the present funnel of opportunities amounts of annual sales (at peak penetration). If you add news products maybe you could also like potential EPS ! Hi snowball, Do you have the analyst report? Can you post the PDF? I'm curious to see what they have to say, just out of curiosity :) I also wonder why they bother covering. It's not like RX will be raising debt any time soon... Link to comment Share on other sites More sharing options...
snowball82 Posted January 22, 2015 Share Posted January 22, 2015 Hi Liberty, the author is Scott Curtis, MEng, CFA scurtis@cantor.com (416) 350-8152. I agree RX don't need money if they don't plan a large acquisition. Link to comment Share on other sites More sharing options...
netnet Posted January 22, 2015 Share Posted January 22, 2015 Interesting company. The business model looks great. Snowball and Liberty, If you don't mind I have four questions What are the key financial ratios for this company? What would turn this into a mistake? What constitutes a fair price for this name?(to buy) Given the ratios, at what price would you sell? Link to comment Share on other sites More sharing options...
snowball82 Posted January 23, 2015 Share Posted January 23, 2015 Hi netnet, first I believe we have to look the business model and the earning power. If the guidance of management is right the current funnel = $ 50 M sales at peak. You could help us to give you a better response if we know this :). :Do you have an idea what could be EPS at $ 50 M sales without futurs new products ? Obsession for no risk can be a costly mindset. Link to comment Share on other sites More sharing options...
LesPaul Posted February 24, 2015 Share Posted February 24, 2015 Noticed this filing in sedar for RX: NI 44-101 Notice of intent to qualify - English http://sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00004638 Link to comment Share on other sites More sharing options...
magno111 Posted February 24, 2015 Share Posted February 24, 2015 Noticed this filing in sedar for RX: NI 44-101 Notice of intent to qualify - English http://sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00004638 what is it? Link to comment Share on other sites More sharing options...
Liberty Posted February 25, 2015 Share Posted February 25, 2015 http://finance.yahoo.com/news/biosyent-releases-q4-full-2014-130000405.html Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now